Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 185.2 M166.5 M160.9 M182.2 M 694.8 M Research & development ———— — Operating income 339.2 M320.4 M406.4 M516.8 M 1.58 B Non-Operating Income, Total 45.1 M-7.5 M16 M-6.8 M 46.8 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 45.1 M-7.5 M16 M-6.8 M 46.8 M Unusual income/expense ———— — Pretax income 293.8 M272.4 M356.8 M465.6 M 1.39 B Equity in earnings ———— — Taxes 35.9 M35 M46.2 M57.8 M 174.9 M Non-controlling/minority interest ———— — After tax other income/expense 13.2 M-1.3 M-16.8 M-1.5 M -6.4 M Net income before discontinued operations 257.9 M237.4 M310.6 M407.8 M 1.21 B Discontinued operations -100 K-200 K-3.8 M-2.9 M -7 M Net income 257.8 M237.2 M306.8 M404.9 M 1.21 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 257.8 M237.2 M306.8 M404.9 M 1.21 B Basic earnings per share (Basic EPS) 2.212.052.673.52 10.45 Diluted earnings per share (Diluted EPS) 2.192.032.653.51 10.38 Average basic shares outstanding 116.7 M115.9 M115 M115.5 M — Diluted shares outstanding 117.6 M116.7 M115.8 M116.3 M — EBITDA 474.3 M458.3 M548.2 M663.1 M 2.14 B EBIT 339.2 M320.4 M406.4 M516.8 M 1.58 B Cost of revenue 988 M1 B1.05 B1.15 B 4.18 B Other cost of goods sold 988 M1 B1.05 B1.15 B 4.18 B Depreciation & amortization (cash flow) 135.1 M137.9 M141.8 M146.3 M 561.1 M